汇宇制药：2025年度业绩快报公告

Group 1 - The company, Huiyu Pharmaceutical, reported a total operating revenue of 998.145 million yuan for the fiscal year 2025, representing a year-on-year decline of 8.79% [2] - The net profit attributable to the parent company's shareholders for the same period was -24.2002 million yuan [2]